{"id":"W2150713593","doi":"10.1309/ajcpv2i0hgpmgbsq","title":"Emerging Technologies for Assessing HER2 Amplification","year":2009,"lang":"en","type":"review","venue":"American Journal of Clinical Pathology","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":140,"is_retracted":false,"has_abstract":true,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"CISH; Chromogenic in situ hybridization; Immunohistochemistry; In situ hybridization; Trastuzumab; Human Epidermal Growth Factor Receptor 2; Fluorescence in situ hybridization; Chromogenic; Concordance; Breast cancer; Pathology; In situ; Fish <Actinopterygii>; Biology; Medicine; Cancer; Internal medicine; Chemistry; Bioinformatics; Genetics; Messenger RNA","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001528811,0.001456965,0.002237984,0.008371918,0.0003058605,0.001016887,0.00178014,0.001246663,0.003458799],"category_scores_gemma":[0.001573229,0.0005735751,0.0007795551,0.004724847,0.0006547044,0.00177508,0.0006559298,0.00161235,0.004394045],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000803441,"about_ca_system_score_gemma":0.0008441166,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001172715,"about_ca_topic_score_gemma":0.001671224,"domain_scores_codex":[0.9991344,0.0001361701,0.0000948838,0.0001584995,0.0004339052,0.00004220059],"domain_scores_gemma":[0.999015,0.0004418521,0.0001268582,0.00003490928,0.0003448243,0.0000366999],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00003552339,0.00006172001,0.0005564387,0.009858603,0.00008427657,0.0003453475,0.00005182458,0.0002100604,0.00510417,0.001289276,0.008457649,0.9739451],"study_design_scores_gemma":[0.00002750085,0.0002003153,0.004859179,0.004117962,0.000308621,0.009498671,0.0001822115,0.0003538806,0.008238032,0.002854078,0.9692771,0.00008241577],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0002873331,0.9960871,0.00120319,0.0001793834,0.0001575393,0.00001609335,0.0000335267,0.00002347372,0.002012391],"genre_scores_gemma":[0.001224347,0.9953296,0.002128593,0.00014934,0.0001393642,0.00002772909,0.00007106931,0.000004058351,0.0009258205],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.008371918,"threshold_uncertainty_score":0.01157081,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.3066237885235228,"score_gpt":0.620314042129059,"score_spread":0.3136902536055363,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}